Dr. Ciara Kelly, MBBCh BAO
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Soft Tissue Sarcoma
Studies Merkel Cell Carcinoma
9 reported clinical trials
9 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
2Merkel Cell Carcinoma
Stage IV
p53 positive
Stage III
Affiliated Hospitals
Clinical Trials Ciara Kelly, MBBCh BAO is currently running
ASTX727
for Peripheral Nerve Sheath Tumor
The purpose of this study is to see whether the study drug ASTX727 is an effective treatment for people who have MPNST with a PCR2 mutation. ASTX727 is a combination of two drugs (cedazuridine and decitabine) that have been designed to target cancer cells with a PCR2 mutation and to disrupt the cells' ability to survive and grow. The study researchers think that the study drug allows decitabine to work better than decitabine given alone.
Recruiting1 award Phase 213 criteria
CRD3874-SI
for Sarcoma
This study will test the safety of a study drug called CRD3874-SI. The researchers will test different doses of CRD3874-SI to find the highest dose that causes few or mild side effects in participants. After the researchers find the highest safe dose of CRD3874-SI, they will test that dose in new groups of participants to help them learn more about the side effects of the study drug and find out whether CRD3874-SI is an effective treatment for for patients with advanced or metastatic malignant solid tumors including sarcoma and Merkel Cell Carcinoma.
Recruiting1 award Phase 114 criteria
More about Ciara Kelly, MBBCh BAO
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ciara Kelly, MBBCh BAO has experience with
- Avelumab
- INBRX-109
- AG-120
- CRD3874-SI
- Pembrolizumab
- Talimogene Laherparepvec (T-VEC)
Breakdown of trials Ciara Kelly, MBBCh BAO has run
Soft Tissue Sarcoma
Merkel Cell Carcinoma
Chondrosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ciara Kelly, MBBCh BAO specialize in?
Ciara Kelly, MBBCh BAO focuses on Soft Tissue Sarcoma and Merkel Cell Carcinoma. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Ciara Kelly, MBBCh BAO currently recruiting for clinical trials?
Yes, Ciara Kelly, MBBCh BAO is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ciara Kelly, MBBCh BAO has studied deeply?
Yes, Ciara Kelly, MBBCh BAO has studied treatments such as Avelumab, INBRX-109, AG-120.
What is the best way to schedule an appointment with Ciara Kelly, MBBCh BAO?
Apply for one of the trials that Ciara Kelly, MBBCh BAO is conducting.
What is the office address of Ciara Kelly, MBBCh BAO?
The office of Ciara Kelly, MBBCh BAO is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.